| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |